The lethal dose 50 (LD50) was determined in female 7-week-old Balb/c mice. Groups of six mice were infected intranasally with 1 × 101, 1 × 102, 1 × 103 and 1 × 104 TCID50 of WNVsyn or WNVwt, respectively. Survival of mice was recorded for a period of 28 days after infection. The 10-fold virus dilutions were titrated shortly after challenge and were used to calculate the LD50 values using the computer program Graph pad Prism 5. Protection was determined after immunization of female 7-week-old Balb/c mice by subcutaneous injections of formalin-inactivated

WNVsyn or WNVwt vaccines in a volume of 100 μl in TBS containing 0.2% Staurosporine price Al(OH)3. Mice were challenged intranasally with 10 μl of PBS (0.01% human serum albumin) containing 2 × 105 TCID50 WNVwt virus. Survival was monitored over a period of 28 days after challenge. For neutralizing antibody determination, Luminespib serum samples were serially diluted with cell culture medium in twofold steps. The serum dilutions were mixed at a ratio of 1:1 with a virus stock suspension adjusted to 1 × 102 TCID50, incubated for 90 ± 15 min at room temperature

and transferred (eight replicates per dilution) to a 96-well microtiter plate seeded with Vero cells. The plates were inspected under a light microscope for the presence of CPE after incubation for 6 days at 37 °C and 5% CO2. The neutralizing titer was

calculated by counting CPE negative wells and by usage of the formula μNT-Titer = (V/2) × 2E((Nneg/8) + 0.5) whereas Nneg is the amount of negative wells and V represents the dilution of the sera in the neutralization mix. For each assay a defined serum positive control was measured and the titer of the viral material was titrated. For detecting infectious viral material in formalin-inactivated WNV antigen preparations, Vero and C6/36 cells were seeded in five 175 cm2 tissue culture flasks and inoculated with individual preparations corresponding to 12 ml of the infectious yield from which the preparations Metalloexopeptidase were derived. After a 10 day incubation period at 37 °C and 5% CO2, supernatant of each flask was titrated by TCID50 and 2 ml supernatant of each flask was carried onto fresh Vero and C6/36 cells. After a 10-day observation period supernatant of each flask was titrated by TCID50. The respective antigen preparations were classified as safe, when no CPE was detectable in individual flasks and no viral material was detected in both TCID50 assays. The amount of WNV antigen in respective samples was determined by means of an ELISA double sandwich system. Briefly, 96-well microtiter plates were coated by overnight incubation at 2–8 °C with an anti-WNV IgG polyclonal serum raised in guinea pigs.